share_log

Retail Investors Are Lotus Health Group Company's (SHSE:600186) Biggest Owners and Were Rewarded After Market Cap Rose by CN¥479m Last Week

Retail Investors Are Lotus Health Group Company's (SHSE:600186) Biggest Owners and Were Rewarded After Market Cap Rose by CN¥479m Last Week

散戶投資者是蓮花健康集團公司(SHSE: 600186)的最大所有者,在上週市值上漲4.79億元人民幣後獲得了回報
Simply Wall St ·  05/01 08:42

Key Insights

關鍵見解

  • Lotus Health Group's significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public
  • A total of 17 investors have a majority stake in the company with 48% ownership
  • Institutions own 10% of Lotus Health Group
  • 蓮花健康集團擁有大量散戶投資者的所有權,這表明關鍵決策受到廣大公衆股東的影響
  • 共有17名投資者持有該公司的多數股權,所有權爲48%
  • 機構擁有蓮花健康集團10%的股份

A look at the shareholders of Lotus Health Group Company (SHSE:600186) can tell us which group is most powerful. We can see that retail investors own the lion's share in the company with 52% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

看看蓮花健康集團公司(SHSE: 600186)的股東可以告訴我們哪個集團最強大。我們可以看到,散戶投資者擁有該公司的大部分股份,所有權爲52%。換句話說,該集團將從對公司的投資中獲得最多(或損失最大)。

As a result, retail investors collectively scored the highest last week as the company hit CN¥7.8b market cap following a 6.5% gain in the stock.

結果,散戶投資者上週集體得分最高,該公司的市值在股價上漲6.5%後達到78億元人民幣。

In the chart below, we zoom in on the different ownership groups of Lotus Health Group.

在下圖中,我們放大了蓮花健康集團的不同所有權組。

ownership-breakdown
SHSE:600186 Ownership Breakdown May 1st 2024
SHSE: 600186 所有權明細 2024 年 5 月 1 日

What Does The Institutional Ownership Tell Us About Lotus Health Group?

關於蓮花健康集團,機構所有權告訴我們什麼?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

機構投資者通常將自己的回報與常見指數的回報進行比較。因此,他們通常會考慮收購相關基準指數中包含的大型公司。

Lotus Health Group already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Lotus Health Group, (below). Of course, keep in mind that there are other factors to consider, too.

蓮花健康集團已經在股份登記處設立了機構。事實上,他們擁有該公司可觀的股份。這表明專業投資者有一定的信譽。但是我們不能僅僅依靠這個事實,因爲機構有時會像所有人一樣進行不良投資。如果兩個大型機構投資者試圖同時拋售股票,股價大幅下跌的情況並不少見。因此,值得查看蓮花健康集團過去的收益軌跡(見下文)。當然,請記住,還有其他因素需要考慮。

earnings-and-revenue-growth
SHSE:600186 Earnings and Revenue Growth May 1st 2024
SHSE: 600186 收益和收入增長 2024 年 5 月 1 日

Lotus Health Group is not owned by hedge funds. The company's largest shareholder is Zhoukou Chengtou Development Group Co., Ltd., with ownership of 13%. With 10% and 5.0% of the shares outstanding respectively, Wuhu Liantai Investment Management Center (Limited Partnership) and Congyang Lianxing Business Service Management Center Partnership Enterprise (Limtied Partnership) are the second and third largest shareholders.

蓮花健康集團不歸對沖基金所有。公司的最大股東是周口城投發展集團有限公司,持股13%。蕪湖聯泰投資管理中心(有限合夥)和叢陽聯興商業服務管理中心合夥企業(有限合夥)分別佔已發行股份的10%和5.0%,是第二和第三大股東。

Our studies suggest that the top 17 shareholders collectively control less than half of the company's shares, meaning that the company's shares are widely disseminated and there is no dominant shareholder.

我們的研究表明,前17名股東共同控制的公司股份不到一半,這意味着該公司的股票被廣泛傳播,沒有占主導地位的股東。

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. As far as we can tell there isn't analyst coverage of the company, so it is probably flying under the radar.

研究機構所有權是衡量和篩選股票預期表現的好方法。通過研究分析師的情緒也可以達到同樣的目的。據我們所知,沒有分析師對該公司進行報道,因此它可能處於雷達之下。

Insider Ownership Of Lotus Health Group

蓮花健康集團的內部所有權

The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

公司內部人員的定義可能是主觀的,並且在不同的司法管轄區之間確實有所不同。我們的數據反映了個人內部人士,至少涵蓋了董事會成員。管理層最終對董事會負責。但是,經理成爲執行委員會成員的情況並不少見,尤其是當他們是創始人或首席執行官時。

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

大多數人認爲內部所有權是積極的,因爲這可能表明董事會與其他股東關係良好。但是,在某些情況下,過多的權力集中在該群體中。

We note our data does not show any board members holding shares, personally. Given we are not picking up on insider ownership, we may have missing data. Therefore, it would be interesting to assess the CEO compensation and tenure, here.

我們注意到,我們的數據並未顯示任何董事會成員個人持有股份。鑑於我們沒有獲得內部所有權,我們可能缺少數據。因此,在這裏評估首席執行官的薪酬和任期會很有趣。

General Public Ownership

一般公有制

The general public, who are usually individual investors, hold a substantial 52% stake in Lotus Health Group, suggesting it is a fairly popular stock. This size of ownership gives investors from the general public some collective power. They can and probably do influence decisions on executive compensation, dividend policies and proposed business acquisitions.

公衆通常是個人投資者,持有蓮花健康集團52%的大量股份,這表明該股相當受歡迎。這種所有權規模賦予了公衆投資者一定的集體權力。他們可以而且可能確實會影響有關高管薪酬、股息政策和擬議業務收購的決策。

Private Company Ownership

私人公司所有權

It seems that Private Companies own 38%, of the Lotus Health Group stock. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

私人公司似乎擁有蓮花健康集團38%的股票。私營公司可能是關聯方。有時,內部人士通過控股私營公司而對上市公司擁有權益,而不是以個人身份擁有權益。儘管很難得出任何寬泛的結論,但值得注意的是,這是一個需要進一步研究的領域。

Next Steps:

後續步驟:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too.

我覺得看看究竟是誰擁有一家公司非常有趣。但是,要真正獲得見解,我們也需要考慮其他信息。

I like to dive deeper into how a company has performed in the past. You can find historic revenue and earnings in this detailed graph.

我喜歡更深入地了解一家公司過去的表現。您可以在這張詳細圖表中找到歷史收入和收入。

Of course this may not be the best stock to buy. So take a peek at this free free list of interesting companies.

當然,這可能不是最值得買入的股票。因此,來看看這份免費的有趣公司名單吧。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論